• 13 Hits
  • 検索条件 : 絞込み (MeSH = Antineoplastic Agents / chemical synthesis*)
生物種 リソース名 タイトル
ヒト・動物細胞 Ca9-22(RCB1976) , HSC-2(RCB1945) , HSC-4(RCB1902) Design, Synthesis and Tumour-Selective Toxicity of Novel 1-[3-{3,5-Bis(benzylidene)-4-oxo-1-piperidino}-3-oxopropyl]-4-piperidone Oximes and Related Quaternary Ammonium Salts.
ヒト・動物細胞 MKN74(RCB1002) , DU145(RCB2143) , PC-3(RCB2145) Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo[h]quinoline scaffolds as anticancer agents.
ヒト・動物細胞 WI-38(RCB0702) Rational evolution of a novel type of potent and selective proviral integration site in Moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound.
ヒト・動物細胞 HGC-27(RCB0500) Synthesis, tautomerism, and antimicrobial, anti-HCV, anti-SSPE, antioxidant, and antitumor activities of arylazobenzosuberones.
ヒト・動物細胞 HSC-2(RCB1945) Synthesis, cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones.
ヒト・動物細胞 A549 , Hep G2 , HeLa Synthesis and antitumor activity of novel pyridinium fullerene derivatives.
ヒト・動物細胞 MKN1(RCB1003) Rational design of small molecule RHOA inhibitors for gastric cancer.
ヒト・動物細胞 Ca9-22(RCB1976) , HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) Quantitative Structure-Cytotoxicity Relationship of 2-Arylazolylchromones and 2-Triazolylchromones.
ヒト・動物細胞 Ca9-22(RCB1976) , HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) A Novel Methodology for Synthesis of 1,5,6-Trisubstituted 2(1H)-Pyrazinones of Biological Interest.
ヒト・動物細胞 Potent anticancer activities of novel aminophenol analogues against various cancer cell lines.
ヒト・動物細胞 A549(RCB0098) , HeLa(RCB0007) Selective antiproliferative activity of caffeic acid phenethyl ester analogues on highly liver-metastatic murine colon 26-L5 carcinoma cell line.
ヒト・動物細胞 HuCCT1(RCB1960) , SH-10-TC(RCB1940) , A431 Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo.
ヒト・動物細胞 293T(RCB2202) Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent.